Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

Nano Nuclear Energy Inc. (NNE)

8-K M&A activity confidence 95% filed 2026-05-29

The filing discloses the entry into and completion of a material acquisition: Nano Nuclear Energy Inc. acquired 100% of the membership interests of Secured Transportation Services LLC (STS) for up to $13.0 million in total consideration (cash, restricted shares, and deferred stock consideration). The transaction closed on May 22, 2026, and is disclosed under Items 1.01 (Entry Into a Material Definitive Agreement) and 2.01 (Completion of Acquisition or Disposition of Assets), with STS becoming a subsidiary of Nano. This is a material M&A event affecting the registrant's business and financial position.

View raw filing on EDGAR →

XCF Global, Inc. (SAFX)

8-K Dilutive issuance confidence 95% filed 2026-05-29

The filing discloses two unregistered private placements of common stock totaling approximately 26.7 million shares (13.3 million each from Brown Stone Capital Ltd. and EEME Energy SPV I, LLC) at $0.15 per share for ~$4 million aggregate proceeds. The securities are issued under Section 4(a)(2) and Regulation D Rule 506(b), and Item 3.02 explicitly incorporates the unregistered sales disclosure. This is a material dilutive equity issuance typical of small-cap companies raising capital through private placements.

View raw filing on EDGAR →

QUANTUM X LABS INC. (QXL)

8-K Other material confidence 72% filed 2026-05-29

The filing discloses a press release announcing the launch of a 50+ physical qubit neutral-atom quantum computer with targets for thousands of qubits by end of H1 2027. This represents a significant product milestone and technological achievement for a quantum computing company, but does not fit neatly into standard 8-K event categories (not earnings, M&A, executive changes, impairment, litigation, or cybersecurity). The announcement is material to investors assessing the company's progress and competitive position in quantum computing, warranting disclosure under Item 8.01 (Other Events).

View raw filing on EDGAR →

UMH PROPERTIES, INC. (UMH-PD)

8-K Exec appointment confidence 75% filed 2026-05-29 Item 5.02

The filing discloses both the retirement of Anna T. Chew as CFO and the appointment of Kevin S. Miller as her successor, effective June 1, 2026. While both events occur, the principal action emphasized in the disclosure structure is Miller's appointment to the CFO role, with detailed background on his qualifications and compensation ($430,000 annual base). The retirement is presented as the context for the appointment rather than as the primary event. This is material as it involves a change in the Company's chief financial officer.

View raw filing on EDGAR →

TAP REAL ESTATE TECHNOLOGIES, INC. (RWAX)

8-K M&A activity confidence 85% filed 2026-05-29

The filing discloses entry into a material definitive agreement under Item 1.01: an Option to Purchase Agreement for the Zermatt Resort in Midway, Utah, with a subsequent addendum extending the option period by 90 days. While the company has not yet completed the acquisition, the option agreement represents a material commitment to a potential real estate acquisition that would be significant to investors assessing the company's strategic direction and capital deployment.

View raw filing on EDGAR →

AtlasClear Holdings, Inc. (ATCHW)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a classic Item 5.07 disclosure of shareholder vote results from AtlasClear's May 27, 2026 annual meeting. The filing presents final voting tallies for three proposals: election of six directors, approval of a 15,000,000-share increase to the 2024 Equity Incentive Plan, and ratification of Haynie & Company as independent auditor. All three proposals passed with majority support, and the detailed vote counts (For/Against/Withheld/Abstentions/Broker Non-Votes) are the core substance of the disclosure.

View raw filing on EDGAR →

Enveric Biosciences, Inc. (ENVB)

8-K Shareholder vote confidence 85% filed 2026-05-29

The filing's primary substantive disclosure is Item 5.07, which reports the results of the 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing details voting outcomes on six director elections, a say-on-pay proposal, a reverse stock split proposal, an authorized stock increase proposal, and auditor ratification. While Item 5.02 addresses new RSU and RSA award agreement forms (an executive compensation matter), the bulk of the 8-K content and materiality centers on the shareholder vote results, particularly the failed Authorized Stock Increase Proposal (427,158 for vs. 555,147 against), which would be material to investors assessing the company's capital structure flexibility.

View raw filing on EDGAR →

Safe Pro Group Inc. (SPAI)

8-K Exec Compensation confidence 95% filed 2026-05-29

The filing discloses compensatory arrangements for two named executives under Item 5.02(e): performance-based stock option grants to CEO Daniyel Erdberg (750,000 options) and CFO Theresa Carlise (150,000 options) with five-year vesting tied to revenue milestones, plus Amendment No. 4 to Ms. Carlise's employment agreement modifying her bonus structure, severance, and change-in-control provisions. These equity grants and employment modifications are material to investors' assessment of executive incentive alignment and retention costs.

View raw filing on EDGAR →

AVAX ONE TECHNOLOGY LTD. (AVX)

8-K Shareholder vote confidence 95% filed 2026-05-29

The filing discloses results of AVAX One Technology's Annual Meeting of Shareholders held on May 29, 2026, under Item 5.07. The company reported voting outcomes on four matters: election of five directors (all approved), ratification of CBIZ CPAs P.C. as independent auditor (approved), approval of a 1:2 to 1:12 reverse stock split (approved), and advisory approval of 2025 named executive officer compensation (approved). These shareholder vote results are material to investors as they reflect governance decisions and corporate actions.

View raw filing on EDGAR →

SkyAI, Inc. (STSSW)

8-K Exec appointment confidence 95% filed 2026-05-29

SkyAI, Inc. entered into an employment agreement with Arthur Levine on May 22, 2026, appointing him as Chief Financial Officer effective immediately. The filing discloses his background, compensation structure ($400,000 base salary plus 50% bonus), equity eligibility, and severance terms. This is a material executive appointment requiring disclosure under Item 5.02 and Item 1.01.

View raw filing on EDGAR →

Clean Energy Technologies, Inc. (CETY)

8-K Delisting risk confidence 98% filed 2026-05-29

Clean Energy Technologies received a written notice from Nasdaq on May 26, 2026, indicating non-compliance with Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for the period ended March 31, 2026. The filing explicitly states that if the Company fails to regain compliance, "the Company's securities will be subject to delisting from Nasdaq." This is a classic delisting risk disclosure under Item 3.01, with material consequences including reduced liquidity, market price impact, and impaired access to capital markets.

View raw filing on EDGAR →

Scienture Holdings, Inc. (SCNX)

8-K Exec appointment confidence 75% filed 2026-05-29

The filing discloses both the resignation of CFO Eric Sherb (May 26, 2026) and the appointment of Dr. Narasimhan Mani as Interim CFO effective the same date. While both events are disclosed, the principal action emphasized is the appointment of Dr. Mani, with substantial detail provided about his qualifications, background, and experience in pharmaceutical and healthcare finance. The appointment of an interim CFO to a critical financial leadership role is material to investors assessing management continuity and financial oversight.

View raw filing on EDGAR →

Calidi Biotherapeutics, Inc. (CLDWW)

8-K Dilutive issuance confidence 95% filed 2026-05-29

The filing discloses an unregistered private placement of an amended and restated warrant to purchase 17,391,304 shares of common stock at $0.23 per share, issued to an accredited investor on May 28, 2026. The transaction is structured under Section 4(a)(2) and Rule 506(b) of the Securities Act, which are classic exemptions for private placements. This represents a significant dilutive issuance of equity securities that would materially affect a reasonable investor's assessment of ownership and capital structure.

View raw filing on EDGAR →

HEALTHY CHOICE WELLNESS CORP. (HCWC)

8-K M&A activity confidence 98% filed 2026-05-29

The filing discloses entry into an Agreement and Plan of Merger on May 27, 2026, whereby HCWC's subsidiary will merge with Host Digital Infrastructure LLC, with Host Digital surviving as a wholly owned subsidiary of HCWC. The transaction involves a $425 million base consideration with Host Digital members receiving approximately 96% of HCWC's outstanding stock post-closing, constituting a material change of control. This is a classic Item 1.01 material definitive agreement disclosure for M&A activity.

View raw filing on EDGAR →

Immix Biopharma, Inc. (IMMX)

8-K Shareholder vote confidence 98% filed 2026-05-29

The 8-K discloses Item 5.07 results from the May 22, 2026 Annual Meeting of stockholders, reporting voting outcomes on two proposals: (1) election of nine directors with detailed vote tallies (For/Withheld/Broker Non-Votes), and (2) ratification of Crowe LLP as independent auditor. This is a textbook shareholder vote results disclosure, material to investors as it confirms board composition and auditor appointment.

View raw filing on EDGAR →

HWH International Inc. (HWH)

8-K Delisting risk confidence 98% filed 2026-05-29

HWH International received a notice from Nasdaq on May 29, 2026 indicating non-compliance with the minimum stockholders' equity requirement of $2.5 million under Listing Rule 5550(b)(1), with reported stockholders' equity of only $2,078,220. The company has 45 days to submit a compliance plan and up to 180 days to regain compliance, or face potential delisting. This is a classic delisting risk disclosure under Item 3.01.

View raw filing on EDGAR →

Caring Brands, Inc. (CABR)

8-K Other material confidence 75% filed 2026-05-29 Item 8.01

The Company disclosed an inadvertent error in its Definitive Proxy Statement filed May 12, 2026, where the record date for the annual meeting was incorrectly stated as May 12, 2026 when the correct date is May 14, 2026. This error affects stockholder voting eligibility and requires filing a revised proxy statement. While not fitting the specific "restatement" category (which applies to financial statements), this is a material disclosure correction that would affect a reasonable investor's ability to participate in the annual meeting vote.

View raw filing on EDGAR →

Wellgistics Health, Inc. (WGRX)

8-K Dilutive issuance confidence 95% filed 2026-05-29

The filing discloses a Securities Purchase Agreement dated May 27, 2026, under which Wellgistics Health issued convertible promissory notes with an aggregate principal amount of $21.1 million and warrants to accredited investors for $16.9 million in cash. The Notes are convertible into common stock at prices ranging from $1.00 to $6.00 per share, and the PIPE Warrants are exercisable at $7.50 per share, with potential gross proceeds of approximately $42.8 million if fully exercised. This is a classic PIPE (private investment in public equity) transaction involving dilutive securities that require stockholder approval under Nasdaq Listing Rule 5635(d) and impose an Exchange Cap of 19.99% of outstanding shares.

View raw filing on EDGAR →

Bandwidth Inc. (BAND)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This 8-K Item 5.07 discloses the results of Bandwidth Inc.'s 2026 Annual Meeting of Stockholders held on May 28, 2026, including voting outcomes on four proposals: election of Class III directors (David A. Morken and Rebecca G. Bottorff), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The filing presents detailed vote tallies (For/Against/Withheld/Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07.

View raw filing on EDGAR →

FingerMotion, Inc. (FNGR)

8-K Earnings release confidence 95% filed 2026-05-29 Item 2.02

FingerMotion issued a news release on May 29, 2026 reporting financial results for fiscal year ended February 28, 2026, disclosing significant declines: revenue fell 32% to $24.13M, gross profit declined 75% to $693,845, and annual loss increased 37% to $7.0M, with segment breakdowns and CEO commentary.

View raw filing on EDGAR →

Freshworks Inc. (FRSH)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a clear Item 5.07 disclosure of shareholder vote results from Freshworks Inc.'s 2026 Annual Meeting held on May 28, 2026. The filing reports voting outcomes for four proposals: election of Class II directors (Roxanne S. Austin, Sameer Gandhi, Frank Pelzer, Dennis Woodside), advisory approval of executive compensation, frequency of say-on-pay votes, and ratification of Deloitte & Touche LLP as independent auditor. All proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and compensation oversight.

View raw filing on EDGAR →

AMASS BRANDS (AMSS)

8-K Dilutive issuance confidence 75% filed 2026-05-29 Item 1.01

The filing discloses a material amendment to an existing warrant that reduces the exercise price from $16.00 to $5.00 per share for a 90-day period, significantly increasing the likelihood and economic incentive for the warrant holder (Streeterville Capital, LLC) to exercise and acquire common stock. This dilutive modification to equity securities is material to investors assessing ownership dilution and capital structure, though the warrant itself was originally issued under a prior Securities Purchase Agreement rather than being a new issuance.

View raw filing on EDGAR →

Life360, Inc. (LIFX)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a clear disclosure of shareholder voting results from Life360's Annual Meeting of Stockholders held on May 28, 2026. The filing reports the certified results of three proposals: election of four Class I directors (Proposal 1), advisory vote on executive compensation (Proposal 2), and ratification of Deloitte & Touche LLP as independent auditor (Proposal 3), with detailed vote tallies for each. This is a quintessential Item 5.07 disclosure and is material as it reflects stockholder approval of key governance matters.

View raw filing on EDGAR →

Community West Bancshares (CWBC)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a clear disclosure of shareholder vote results from Community West Bancshares' Annual Meeting of Shareholders held on May 27, 2026. The filing presents tabulated voting results for three matters: election of 13 directors, ratification of Baker Tilly LLP as independent auditor, and a non-binding advisory vote on executive compensation. These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.

View raw filing on EDGAR →

BECTON DICKINSON & CO (BDX)

8-K Other material confidence 72% filed 2026-05-29 Item 7.01

BD discloses resumption of ChloraPrep™ and PurPrep™ shipments after a voluntary hold in response to an FDA Warning Letter for the El Paso manufacturing facility. While the disclosure emphasizes acceptable testing results and no patient safety signals, the underlying regulatory action (FDA Warning Letter) and product shipment disruption are material to investors assessing operational and regulatory risk, even though the immediate disclosure is framed positively.

View raw filing on EDGAR →

Maplebear Inc. (CART)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a classic Item 5.07 disclosure reporting the results of Maplebear Inc.'s 2026 Annual Meeting of Stockholders held on May 22, 2026. The filing presents voting results for three proposals: election of two Class III directors (Meredith Kopit Levien and Lily Sarafan both elected), ratification of PricewaterhouseCoopers LLP as independent auditor, and non-binding advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.

View raw filing on EDGAR →

SILGAN HOLDINGS INC (SLGN)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

Silgan Holdings held its annual meeting of stockholders on May 26, 2026, with voting results on four matters: election of three directors, approval of the First Amendment to the 2004 Stock Incentive Plan, ratification of Ernst & Young LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation.

View raw filing on EDGAR →

Ellington Financial Inc. (EFC-PD)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

Ellington Financial held its 2026 Annual Meeting of Stockholders on May 28, 2026, with shareholders voting on four proposals: election of directors, advisory say-on-pay vote, ratification of PricewaterhouseCoopers LLP as auditors, and approval of the 2026 Equity Incentive Plan. The filing discloses detailed voting results (For, Against, Abstentions, and Broker Non-Votes) for each proposal.

View raw filing on EDGAR →

CASTLE BIOSCIENCES INC (CSTL)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a classic Item 5.07 disclosure reporting the results of Castle Biosciences' 2026 annual meeting of stockholders held on May 28, 2026. The filing presents voting results for four proposals: election of three Class I directors (Ellen Goldberg, Miles D. Harrison, Tiffany P. Olson), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the non-employee director compensation policy. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.

View raw filing on EDGAR →

Fathom Holdings Inc. (FTHM)

8-K Delisting risk confidence 95% filed 2026-05-29 Item 3.01

Fathom Holdings received a notification letter from Nasdaq on May 22, 2026, indicating non-compliance with Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for the period ended March 31, 2026. The company has 60 days to submit a compliance plan and faces potential delisting if it cannot regain compliance. This is a classic delisting-risk disclosure under Item 3.01, as it documents the company's failure to satisfy a continued listing standard and the procedural pathway toward potential delisting.

View raw filing on EDGAR →

Meta Platforms, Inc. (META)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a clear disclosure of shareholder voting results from Meta's May 27, 2026 annual meeting of shareholders. The filing reports detailed vote tallies for all twelve proposals, including director elections (all twelve nominees elected), ratification of Ernst & Young LLP as auditor (approved), and twelve shareholder proposals (all rejected). This is a quintessential Item 5.07 disclosure and is material to investors as it documents the outcome of significant corporate governance matters and shareholder engagement.

View raw filing on EDGAR →

Skye Bioscience, Inc. (SKYE)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

Skye Bioscience held its 2026 Annual Meeting of Stockholders on May 26, 2026, with shareholders voting on four proposals: election of six directors, ratification of CBIZ CPAs P.C. as auditor, approval of a Charter Amendment to increase authorized common shares from 100 million to 300 million, and advisory approval of named executive officer compensation. All proposals received final vote tallies disclosed in the filing.

View raw filing on EDGAR →

OCTAVE SPECIALTY GROUP INC (OSG)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This Item 5.07 filing discloses the final voting results from Octave Specialty Group's Annual Meeting of Stockholders held on May 28, 2026, including election of seven directors, advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as auditor, and approval of the 2026 Incentive Compensation Plan. The detailed vote tallies for each action are the core disclosure, making this a textbook shareholder_vote_results event that is material to investors assessing corporate governance and executive compensation matters.

View raw filing on EDGAR →

SEACOAST BANKING CORP OF FLORIDA (SBCF)

8-K Exec departure confidence 95% filed 2026-05-29 Item 5.02

H. Gilbert Culbreth, Jr. formally resigned from the Board of Directors of Seacoast Banking Corporation of Florida effective June 15, 2026, after serving since 2008 and as a member of the compensation and governance committee. This is a clear director departure disclosure under Item 5.02, material to investors as board composition changes affect corporate governance and oversight.

View raw filing on EDGAR →

Spyre Therapeutics, Inc. (SYRE)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

Shareholders voted at the May 27, 2026 Annual Meeting on four proposals: election of three Class I directors (McKenna, Turtle, Stelzer), advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditor, and approval of the amended ESPP. Final vote tallies were disclosed for each proposal.

View raw filing on EDGAR →

Onfolio Holdings, Inc (ONFOW)

8-K Delisting risk confidence 98% filed 2026-05-29 Item 3.01

Onfolio received a written notice from Nasdaq on May 26, 2026, stating non-compliance with Listing Rule 5550(b)(1) due to stockholders' equity of $1,216,603 falling below the required $2,500,000 minimum. The company also fails to meet alternative continued listing standards. This is a classic delisting risk disclosure under Item 3.01, with a 45-day cure period and potential suspension or delisting if compliance is not achieved.

View raw filing on EDGAR →

HERTZ CORP

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a clear disclosure of shareholder voting results from Hertz Global Holdings' 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing reports final voting tallies for three matters: election of two directors (Lucy Clark Dougherty and Evangeline Vougessis), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officers' compensation. This is a textbook Item 5.07 shareholder vote results disclosure, and the outcomes (both directors elected, auditor ratified, compensation approved) are material to investors' understanding of corporate governance and board composition.

View raw filing on EDGAR →

Hancock Park Corporate Income, Inc.

8-K Other material confidence 45% filed 2026-05-29 Item 2.02

The filing discloses a Board declaration of a $0.01 per common share distribution with a 1.7% annualized yield, filed under Item 2.02 (Results of Operations and Financial Condition). While distribution declarations are material to shareholders, this does not fit cleanly into earnings_release (no financial results disclosed), exec_compensation (not executive-focused), or other specific event types. The disclosure is material to investors assessing income and capital allocation, but the Item 2.02 placement and lack of detailed financial results create ambiguity about whether this is a routine distribution announcement or a material financial event warranting 8-K disclosure.

View raw filing on EDGAR →

Trade Desk, Inc. (TTD)

8-K Exec departure confidence 75% filed 2026-05-29 Item 5.02

The filing discloses Samantha Jacobson's resignation as an officer and employee of the Company, effective May 18, 2026. While the section also describes her new compensation as a non-employee director, the principal disclosed action is her departure from officer/employee status. The material event is the executive departure, with the director compensation arrangement being a secondary consequence of that transition.

View raw filing on EDGAR →

DigitalBridge Group, Inc. (DBRG-PJ)

8-K Dilutive issuance confidence 92% filed 2026-05-29 Item 3.02

DigitalBridge issued 2,358,601 shares of class A common stock on May 28, 2026 in satisfaction of an OP unit redemption request under the Section 4(a)(2) exemption, representing a material dilutive equity issuance to an existing OP unit holder.

View raw filing on EDGAR →

DigitalBridge Group, Inc. (DBRG-PJ)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

DigitalBridge held its Annual Meeting of Stockholders on May 28, 2026, with stockholders voting on four proposals: election of nine directors, advisory vote on executive compensation, approval of an omnibus stock incentive plan amendment increasing authorized shares by 6,000,000, and ratification of Ernst & Young LLP as independent auditor.

View raw filing on EDGAR →

Unusual Machines, Inc. (UMAC)

8-K Exec Compensation confidence 85% filed 2026-05-29 Item 8.01

The filing discloses an amendment to the Management Services Agreement with 8 Consulting LLC (the CEO's service provider) that modifies the annual service fee to $350,000, a material compensation change that was previously approved by the Compensation Committee. This is a compensatory arrangement modification for an executive officer, fitting the exec_compensation category.

View raw filing on EDGAR →

Sunshine Biopharma Inc. (SBFMW)

8-K Shareholder vote confidence 92% filed 2026-05-29 Item 5.07

This Item 5.07 discloses shareholder approval by written consent on May 28, 2026, by majority holder Dr. Steve N. Slilaty (86% voting power) authorizing issuance of over 20% of outstanding shares at a discount to Nasdaq minimum price and adjustments to Series C Warrants. The disclosure of shareholder voting results—even by written consent rather than meeting vote—is the core event, and the authorization of dilutive equity issuance at a discount is material to investors.

View raw filing on EDGAR →

NeoVolta Inc. (NEOVW)

8-K Dilutive issuance confidence 92% filed 2026-05-29 Item 1.01

NeoVolta completed a registered public offering of 12,195,122 shares at $2.05 per share on May 29, 2026, raising approximately $23.5 million in net proceeds. The substantial equity issuance represents significant dilution to existing shareholders and was disclosed under Item 1.01 (Entry into a Material Definitive Agreement) via the underwriting agreement executed on May 27, 2026.

View raw filing on EDGAR →

CLOUDASTRUCTURE, INC. (CSAI)

8-K Delisting risk confidence 98% filed 2026-05-29 Item 3.01

Cloudastructure received a notice from Nasdaq on May 26, 2026, indicating non-compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for the period ended March 31, 2026. The company has 60 days to submit a compliance plan and up to 180 days to regain compliance, with explicit acknowledgment that "there is no assurance that Nasdaq will accept the Company's plan to regain compliance." This is a classic delisting-risk disclosure under Item 3.01.

View raw filing on EDGAR →

Kiniksa Pharmaceuticals International, plc (KNSA)

8-K Shareholder vote confidence 98% filed 2026-05-29 Item 5.07

This is a clear Item 5.07 disclosure of shareholder voting results from Kiniksa's Annual Meeting of Shareholders held on May 29, 2026. The filing presents detailed vote tallies for eight proposals including director re-elections (Proposal 1), auditor appointments (Proposals 2-4), financial statements (Proposal 5), and executive compensation approvals (Proposals 6-8). All proposals passed. This is material as it documents the outcome of the company's annual shareholder meeting and confirms governance decisions including board composition and auditor retention.

View raw filing on EDGAR →

Amerant Bancorp Inc. (AMTB)

8-K Exec appointment confidence 95% filed 2026-05-29 Item 5.02

Adrian Rodriguez was appointed as Executive Vice President and Chief Operating Officer effective May 26, 2026, transitioning from his interim role since November 2025. This is a permanent appointment to a material C-suite position (COO) at the registrant, which would affect a reasonable investor's assessment of management continuity and operational leadership. The disclosure centers on the appointment action itself, not compensation terms (which remain pending determination).

View raw filing on EDGAR →

Meridian Corp (MRBK)

8-K Shareholder vote confidence 95% filed 2026-05-29 Item 5.07

This Item 5.07 disclosure reports the results of Meridian Corp's Annual Meeting of Shareholders held on May 28, 2026, including election of three Class C directors (Christopher J. Annas, Edward J. Hollin, and Anthony M. Imbesi), approval of executive compensation via say-on-pay vote, and ratification of Crowe LLP as independent auditor. The filing presents vote tallies for each proposal, which is the core content of shareholder vote results disclosures.

View raw filing on EDGAR →

Carvana Auto Receivables Trust 2026-P2

8-K M&A activity confidence 92% filed 2026-05-29 Item 1.01

Carvana Auto Receivables Trust 2026-P2 entered into material definitive agreements for the securitization and issuance of approximately $X million in asset-backed notes on May 27, 2026, involving the sale of retail installment contracts from Carvana and Carvana FAC to the Depositor, transfer to the Issuing Entity, and ultimate securitization through issuance of Class A-1 through Class D notes.

View raw filing on EDGAR →